150 related articles for article (PubMed ID: 34850168)
1. Treat the VTE and worry less about the hemorrhage: A sigh of relief or is the jury still out for therapeutic anticoagulation in high-grade glioma?
Taylor JW
Neuro Oncol; 2022 Mar; 24(3):465-466. PubMed ID: 34850168
[No Abstract] [Full Text] [Related]
2. Venous thrombosis in patients with high-grade glioma.
Taillibert S; Taillandier L; Le Rhun E
Curr Opin Oncol; 2015 Nov; 27(6):516-21. PubMed ID: 26447877
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents.
Perry JR
Curr Opin Neurol; 2010 Dec; 23(6):592-6. PubMed ID: 20881488
[TBL] [Abstract][Full Text] [Related]
4. Management of venous thromboembolism in patients with glioma.
Al Megren M; De Wit C; Al Qahtani M; Le Gal G; Carrier M
Thromb Res; 2017 Aug; 156():105-108. PubMed ID: 28624717
[TBL] [Abstract][Full Text] [Related]
5. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
Jo J; Donahue J; Sarai G; Petroni G; Schiff D
Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073
[TBL] [Abstract][Full Text] [Related]
6. Safety of apixaban for venous thromboembolic primary prophylaxis in patients with newly diagnosed malignant glioma.
Thomas AA; Wright H; Chan K; Ross H; Prasad P; Goodwin A; Holmes CE
J Thromb Thrombolysis; 2022 Feb; 53(2):479-484. PubMed ID: 34347201
[TBL] [Abstract][Full Text] [Related]
7. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin.
Mantia C; Uhlmann EJ; Puligandla M; Weber GM; Neuberg D; Zwicker JI
Blood; 2017 Jun; 129(25):3379-3385. PubMed ID: 28468796
[TBL] [Abstract][Full Text] [Related]
8. Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
Menapace LA; McCrae KR; Khorana AA
Thromb Res; 2016 Apr; 140 Suppl 1():S93-8. PubMed ID: 27067987
[TBL] [Abstract][Full Text] [Related]
9. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.
Houghton DE; Key NS; Zakai NA; Laux JP; Shea TC; Moll S
Leuk Lymphoma; 2017 Nov; 58(11):2573-2581. PubMed ID: 28393576
[TBL] [Abstract][Full Text] [Related]
10. Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients.
Norden AD; Bartolomeo J; Tanaka S; Drappatz J; Ciampa AS; Doherty LM; Lafrankie DC; Ruland S; Quant EC; Beroukhim R; Wen PY
J Neurooncol; 2012 Jan; 106(1):121-5. PubMed ID: 21706358
[TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.
Imberti D; Pomero F; Mastroiacovo D
Blood Transfus; 2020 Jan; 18(1):49-57. PubMed ID: 31184579
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Overview of Direct Oral Anticoagulants for the Management of Venous Thromboembolism.
Comerota AJ; Ramacciotti E
Am J Med Sci; 2016 Jul; 352(1):92-106. PubMed ID: 27432042
[TBL] [Abstract][Full Text] [Related]
13. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
[TBL] [Abstract][Full Text] [Related]
14. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
Couturaud F; Kearon C
Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors.
Mantia C; Zwicker JI
Cancer Treat Res; 2019; 179():179-189. PubMed ID: 31317488
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effectiveness and safety for low versus full dose of apixaban during extended phase oral anticoagulation in patients with venous thromboembolism.
DeRemer CE; Dietrich EA; Kang HR; Huang PL; Lo-Ciganic WH; Park H
J Intern Med; 2022 Jun; 291(6):877-885. PubMed ID: 35192737
[TBL] [Abstract][Full Text] [Related]
17. A critical balance: managing coagulation in patients with glioma.
Morgan ER; Mason WP; Maurice C
Expert Rev Neurother; 2016 Jul; 16(7):803-14. PubMed ID: 27101362
[TBL] [Abstract][Full Text] [Related]
18. The utility of routine head CT for hemorrhage surveillance in post-craniotomy patients undergoing anticoagulation for venous thromboembolism.
Hacker E; Ozpinar A; Fernandes D; Agarwal N; Gross BA; Alan N
J Clin Neurosci; 2021 Mar; 85():78-83. PubMed ID: 33581795
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolic disease in patients with high-grade glioma.
Perry JR
Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv73-80. PubMed ID: 23095833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
